Try our beta test site

Women At Risk: The High Risk Breast Cancer Program (WAR)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2009 by New York Presbyterian Hospital.
Recruitment status was:  Recruiting
Women At Risk
Information provided by:
New York Presbyterian Hospital Identifier:
First received: December 17, 2009
Last updated: NA
Last verified: October 2009
History: No changes posted
The purpose of this study is to increase understanding of women who are at high risk for developing breast cancer. Data from this group will be collected and entered into a registry. This registry serves as a clinical database to support research in prevention, early detection and treatment of breast cancer.

Breast Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Women At Risk: The High Risk Breast Cancer Program

Resource links provided by NLM:

Further study details as provided by New York Presbyterian Hospital:

Estimated Enrollment: 2000
Study Start Date: January 1991
Detailed Description:
This is a longitudinal cohort study that collects data of eligible women at risk for developing breast cancer. Patient information will be entered into a secured computerized database that is used for research on the prevention, early detection and treatment of breast cancer.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients of the breast center at New York Presbyterian Hosptial/ Columbia University Medical Center

Inclusion Criteria:

  • one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal breast cancer
  • two or more first-degree relatives with post-menopausal breast cancer
  • tested positive for a BRCA1 or BRCA2 mutation
  • a history of biopsy-proven atypical ductal hyperplasia or atypical lobular hyperplasia
  • a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)

Exclusion Criteria:

  • DCIS (ductal carcinoma in situ)
  • previous diagnosis of breast cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01034891

United States, New York
Women At Risk, Columbia University Medical Center
New York, New York, United States, 10032
Women At Risk, Weill Cornell
New York, New York, United States, 10065
Sponsors and Collaborators
New York Presbyterian Hospital
Women At Risk
Principal Investigator: Kathie-Ann Joseph, MD, MPH Columbia University/New York Presbyterian Hospital
  More Information

Additional Information:
Responsible Party: Amy Whiffen, Women At Risk Identifier: NCT01034891     History of Changes
Other Study ID Numbers: AAAA4649 
Study First Received: December 17, 2009
Last Updated: December 17, 2009

Keywords provided by New York Presbyterian Hospital:
BRCA mutation
benign breast disease
family history of breast cancer
strong family history of breast cancer
atypical ductal hyperplasia
atypical lobular hyperplasia
high risk for breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on February 20, 2017